Children's Kidney Patient Support Group
Understanding the emotional well-being of our patients with long-term kidney disease is essential. The Children’s Kidney Patient Support Group aims to enhance psychosocial adjustment and empower patients and their families to lead fulfilling lives.
Activities organised by child life therapists, art therapists and psychologists help young patients and their families manage emotions and anxiety. Highlights include the Annual Children's Kidney Camp, which started in 2000 and offers unique experiences and fosters strong resilience and friendships among our patients, including dialysis and transplant patients.Throughout the years, our patients have camped at various locations including Outward Bound School at Pulau Ubin, Sarimbun Scouts' camp, Sentosa and have even gone on a cruise.which .
This support group also organises regular workshops for patients and their families.
For more information, contact Ms Cheng Peizhi at (65) 6772 2447 or via email at
[email protected].
Paediatric Chronic Kidney Disease Programme
The Paediatric Chronic Kidney Disease Programme offers long-term dialysis and renal transplantation for paediatric patients with renal failure. Since its inception in 1988, over 125 children and adolescents have participated in this programme, integrating schooling and employment into their treatment plans.
The home-based automated peritoneal dialysis programme allows patients to receive dialysis at night in their homes, with 30 to 40 patients currently on this system. Centre-based chronic haemodialysis and home haemodialysis are also available, with in-depth, one-to-one training provided by our nurses.
The programme aims to provide every child with a chance for a renal transplant, for an optimum quality of life and long-term outcomes. The transplant programme began in 1989 when the first living-related paediatric renal transplant was performed in Singapore. Since then, more than 70 patients have received transplantations here,, where two-thirds of these were from living donors. With individualised immunosuppression regimes , and early detection of patients at higher risk of graft rejection and opportunistic infections, the programme’s patient and graft survival rates have been consistently comparable to renowned centres in North America.